Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.2.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-15698.6Japan
B.1.578NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-15698.6Japan
B.1.1.63NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-15698.6Japan
CM.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-15690.9US
BA.2.2.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-15686.3China
BA.2.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-15686.3China
XBB.1.38.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-15680China
FL.39.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-15680China
JN.3.1ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-15679.3Japan
AY.92 (Delta)ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-15679.3Japan
GE.1.2.2ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-15679.3Japan
KT.1.2ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-15679.3Japan
BA.4.1.8ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-15679.3Japan
JH.2ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-15679.3Japan
CY.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-15679Thailand
B.19ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-15678.1Japan
FL.17.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-15666.2Singapore
B.1.1.270SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-15662Japan
BA.5.11ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-15654.7China
B.1.602ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-15654.7China
B.1.571SYoung-STATACATGTCTCTGGGACCA20452176321782F-15650.7Singapore
B.1.258.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-15650.7Singapore
BA.2.56.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-15650.7Singapore
U.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-15650.7Singapore
GK.2.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-15650.7Singapore
B.45SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-15648.9China
B.1.1.334SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-15633.7Singapore
ML.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
B.1.115ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
BF.35ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
XBC.1.3.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
JN.11.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
XDLORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
EG.10ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
FL.17.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
B.1.1.27ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
XBB.1.23ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
B.1.1.391ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
B.1.118ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
BA.2.3.21ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
FL.2.2ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
BA.2.86.7ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
FL.39ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
EG.1.7ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
EG.1.4.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
FL.15.2ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
EG.2.2ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
HN.4.1.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
FL.17.2ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
EG.12ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used